ABT Abbott Laboratories Common Stock
$117,25
Cena · Sie 24, 2026
Dane fundamentalne na dzień Lip 28, 2026
Zakres 52 tyg.
$82–$137
64% of range
Ocena Analityków
BUY
33 analysts
Cena Docelowa
$119
+2% upside
P/E (TTM)
31.5
ROE
13.1%
Marża Zysku Netto
14.7%
O Abbott Laboratories Common Stock Przegląd firmy z Wikipedii
Abbott Laboratories – amerykańskie przedsiębiorstwo farmaceutyczne założone w 1888 roku, mające swoją siedzibę w Abbott Park, w stanie Illinois, w Stanach Zjednoczonych.
Czytaj więcej
Abbott Laboratories – amerykańskie przedsiębiorstwo farmaceutyczne założone w 1888 roku, mające swoją siedzibę w Abbott Park, w stanie Illinois, w Stanach Zjednoczonych.
Abbott Laboratories jako pierwsze stworzyło tester na HIV. W swojej ofercie posiada m.in.: lek na reumatoidalne zapalenie stawów, konwulsje oraz syntetyczną tyroksynę. Abbott posiada także szeroki zakres produktów diagnostycznych. W Polsce przedsiębiorstwo działa poprzez spółkę zależną Abbott Laboratories Poland Sp. z o.o.
Źródło: Wikipedia, CC BY-SA 4.0 · Zobacz w Wikipedii ↗
ABT Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$117.25
Kapitalizacja Rynkowa
$234.29B
P/E (TTM)
31.5
EPS (TTM)
$3.72
Przychody (TTM)
$44.33B
Stopa dywidendy
1.8%
ROE
13.1%
D/E Dług/Kapitał
0.2
Zakres 52 tyg.
$82 – $137
ABT Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$44.33B
2016-12-31
→
2025-12-31
EPS
$3.72
2016-12-31
→
2025-12-31
Wolny przepływ pieniężny
$7.39B
2016-12-31
→
2025-12-31
Marże
14.7%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
ABT
Mediana porównawcza
P/E (TTM)
31.5
27.5
P/S (TTM)
5.3
3.3
P/B
4.5
3.1
EV / EBITDA
29.6
—
Price / FCF (Cena / FCF)
31.7
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
ABT
Mediana porównawcza
Operating Margin (Marża Operacyjna)
18.2%
—
Net Profit Margin (Marża Zysku Netto)
14.7%
-34.5%
ROA
7.8%
-20.0%
ROE
13.1%
-15.8%
ROIC
9.5%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
ABT
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.2
—
Current Ratio (Wskaźnik bieżący)
1.6
1.4
Quick Ratio (Wskaźnik Szybkości)
1.0
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
ABT
Mediana porównawcza
Revenue YoY (Przychody R/R)
5.7%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
0.51%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
5.1%
—
EPS YoY
-51.3%
—
Net Income YoY (Zysk Netto R/R)
-51.3%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
ABT
Mediana porównawcza
Payout Ratio (Wskaźnik Wypłaty Dywidendy)
63.1%
—
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy
1.8%
Wskaźnik Wypłaty Dywidendy
63.1%
CAGR dywidendy 5-letni
—
| Data ex-dywidendy | Kwota |
|---|---|
| 15 lipca 2026 | $0,6300 |
| 15 kwietnia 2026 | $0,6300 |
| 15 stycznia 2026 | $0,6300 |
| 15 października 2025 | $0,5900 |
| 15 lipca 2025 | $0,5900 |
| 15 kwietnia 2025 | $0,5900 |
| 15 stycznia 2025 | $0,5900 |
| 15 października 2024 | $0,5500 |
| 15 lipca 2024 | $0,5500 |
| 12 kwietnia 2024 | $0,5500 |
| 11 stycznia 2024 | $0,5500 |
| 12 października 2023 | $0,5100 |
| 13 lipca 2023 | $0,5100 |
| 13 kwietnia 2023 | $0,5100 |
| 12 stycznia 2023 | $0,5100 |
| 13 października 2022 | $0,4700 |
| 14 lipca 2022 | $0,4700 |
| 13 kwietnia 2022 | $0,4700 |
| 13 stycznia 2022 | $0,4700 |
| 14 października 2021 | $0,4500 |
ABT Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
33 analityków
- Mocne kupno 11 33,3%
- Kup 13 39,4%
- Trzymaj 9 27,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
25 analityków · 2026-08-20
Mediana
$120.00
Teraz
$117.25
Niski
$103.00
Wysoki
$135.00
Średni cel
$120.00
+2,3%
Średnia cel
$119.40
+1,8%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.00%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $1.31 | $1.29 | 0.02% |
| 31 marca 2026 | $1.15 | $1.16 | -0.01% |
| 31 grudnia 2025 | $1.50 | $1.51 | -0.01% |
| 30 września 2025 | $1.30 | $1.31 | -0.01% |
| 30 czerwca 2025 | $1.26 | $1.27 | -0.01% |
| 31 marca 2025 | $1.09 | $1.08 | 0.01% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B | $27.39B | $20.85B | $20.41B | $20.25B | |
| Cost of Revenue | $19.32B | $18.71B | $17.98B | $19.14B | $18.54B | $15.00B | $13.23B | $12.71B | $12.41B | $9.09B | $8.75B | $9.22B | |
| R&D Expense | $2.94B | $2.84B | $2.74B | $2.89B | $2.74B | $2.42B | $2.44B | $2.30B | $2.26B | · | · | · | |
| SG&A Expense | $12.33B | $11.70B | $10.95B | $11.25B | $11.32B | $9.70B | $9.77B | $9.74B | $9.18B | $6.74B | $6.79B | $6.53B | |
| Operating Expenses | $36.27B | $35.12B | $33.63B | $35.29B | $34.65B | $29.25B | $27.37B | $26.93B | $25.83B | $17.83B | $17.54B | $17.65B | |
| Operating Income | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B | $5.36B | $4.53B | $3.65B | $1.56B | $3.03B | $2.87B | $2.60B | |
| Interest Expense | · | · | $637M | $558M | $533M | $546M | $670M | $826M | $904M | $431M | $163M | $150M | |
| Interest Income | $308M | $344M | $385M | $183M | $43M | $46M | $94M | $105M | $124M | $99M | $105M | $77M | |
| Other Non-op | $548M | $376M | $479M | $321M | $277M | $103M | $191M | $139M | $1.41B | $-786M | $281M | $-14M | |
| Pretax Income | $8.47B | $7.01B | $6.66B | $8.31B | $8.21B | $4.97B | $4.08B | $2.87B | $2.23B | $1.41B | $3.18B | $2.52B | |
| Income Tax | $1.94B | $-6.39B | $941M | $1.37B | $1.14B | $497M | $390M | $539M | $1.88B | $350M | $577M | $797M | |
| Net Income | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B | $477M | $1.40B | $4.42B | $2.28B | |
| EPS (Basic) | $3.73 | $7.67 | $3.28 | $3.94 | $3.97 | $2.52 | $2.07 | $1.34 | $0.27 | $0.94 | $2.94 | $1.50 | |
| EPS (Diluted) | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 | $2.50 | $2.06 | $1.33 | $0.27 | $0.94 | $2.92 | $1.49 | |
| Shares (Basic) | 1,741,000,000 | 1,740,000,000 | 1,740,000,000 | 1,753,000,000 | 1,775,000,000 | 1,773,000,000 | 1,768,000,000 | 1,758,000,000 | 1,740,000,000 | 1,477,000,000 | 1,496,000,000 | 1,516,000,000 | |
| Shares (Diluted) | 1,748,000,000 | 1,748,000,000 | 1,749,000,000 | 1,764,000,000 | 1,789,000,000 | 1,786,000,000 | 1,781,000,000 | 1,770,000,000 | 1,749,000,000 | 1,483,000,000 | 1,506,000,000 | 1,527,000,000 | |
| EBITDA | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B | $5.36B | $4.53B | $3.65B | $1.73B | $3.19B | $2.87B | $2.60B |
Bilans 27
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.52B | $7.62B | $6.90B | $9.88B | $9.80B | $6.84B | $3.86B | $3.84B | $9.41B | $18.62B | $5.00B | $4.06B | |
| Short-term Investments | $417M | $351M | $383M | $288M | $450M | $310M | $280M | $242M | $203M | $155M | $1.12B | $397M | |
| Receivables | $7.93B | $6.92B | $6.57B | $6.22B | $6.49B | $6.41B | $5.42B | $5.18B | $5.25B | $3.25B | $3.42B | $3.59B | |
| Inventory | $6.49B | $6.19B | $6.57B | $6.17B | $5.16B | $5.01B | $4.32B | $3.80B | $3.60B | $2.43B | $2.60B | $2.64B | |
| Other Current Assets | · | · | · | · | · | · | · | · | $1.67B | $1.81B | $1.91B | $1.98B | |
| Current Assets | $26.00B | $23.66B | $22.67B | $25.22B | $24.24B | $20.44B | $15.67B | $14.63B | $20.15B | $26.78B | $14.15B | $13.56B | |
| PP&E (Net) | $11.82B | $10.66B | $10.15B | $9.16B | $8.96B | $9.03B | $8.04B | $7.56B | $7.61B | $5.71B | $5.73B | $5.93B | |
| PP&E (Gross) | $25.22B | $22.74B | $21.93B | $20.21B | $19.36B | $18.79B | $16.80B | $15.71B | $15.27B | $12.37B | $12.38B | $12.63B | |
| Accum. Depreciation | $13.41B | $12.08B | $11.78B | $11.05B | $10.40B | $9.76B | $8.76B | $8.14B | $7.66B | $6.66B | $6.65B | $6.70B | |
| Goodwill | $24.04B | $23.11B | $23.68B | $22.80B | $23.23B | $23.74B | $23.20B | $23.25B | $24.02B | $7.68B | $9.64B | $10.07B | |
| Intangibles | $5.53B | $6.65B | $8.81B | $10.45B | $12.74B | $14.78B | $17.02B | $18.94B | $21.47B | $4.54B | $5.56B | $6.20B | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $2.12B | $3.29B | |
| Total Assets | $86.71B | $81.41B | $73.21B | $74.44B | $75.20B | $72.55B | $67.89B | $67.17B | $76.25B | $52.67B | $41.25B | $41.21B | |
| Short-term Debt | · | · | · | · | $0 | $213M | $201M | $200M | $206M | $1.32B | $3.13B | $4.38B | |
| Current Liabilities | $16.50B | $14.16B | $13.84B | $15.49B | $13.11B | $11.91B | $10.86B | $9.01B | $8.91B | $6.66B | $9.19B | $10.47B | |
| Capital Leases | $931M | $896M | $949M | $943M | $956M | $902M | $755M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $860M | |
| Other Non-current Liabilities | $2.54B | $2.59B | $3.47B | $3.80B | $3.69B | · | · | · | $9.03B | $4.55B | $4.86B | $5.60B | |
| Long-term Debt | $12.93B | $14.12B | $14.68B | $16.77B | $18.05B | $18.53B | $17.94B | $19.37B | $27.72B | $20.68B | $5.87B | $3.45B | |
| Total Debt | $12.93B | $14.12B | $14.68B | $16.77B | $18.05B | $18.75B | $18.14B | $19.57B | $27.92B | $22.01B | $9.00B | $7.84B | |
| Common Stock | $25.53B | $25.15B | $24.87B | $24.71B | $24.47B | $24.14B | $23.85B | $23.51B | $23.21B | $13.03B | $12.73B | $12.38B | |
| Retained Earnings | $49.78B | $47.26B | $37.55B | $35.26B | $31.53B | $27.63B | $25.85B | $24.56B | $23.98B | $25.57B | $25.76B | $22.87B | |
| Treasury Stock | $17.18B | $16.84B | $15.98B | $15.23B | $11.82B | $10.04B | $10.15B | $9.96B | $10.22B | $10.79B | $10.62B | $8.68B | |
| AOCI | $-6.00B | $-7.91B | $-7.84B | $-8.05B | $-8.37B | $-8.95B | $-8.46B | $-7.59B | $-6.06B | $-7.26B | $-6.66B | $-5.05B | |
| Stockholders' Equity | $52.13B | $47.66B | $38.60B | $36.69B | $35.80B | $32.78B | $31.09B | $30.52B | $30.90B | $20.54B | $21.21B | $21.53B | |
| Liabilities + Equity | $86.71B | $81.41B | $73.21B | $74.44B | $75.20B | $72.55B | $67.89B | $67.17B | $76.25B | $52.67B | $41.25B | $41.21B | |
| Shares Outstanding | 1,996,795,525 | 1,991,472,630 | 1,987,883,852 | 1,986,519,278 | 1,985,273,421 | 1,981,156,896 | 1,976,855,085 | 1,971,189,465 | 1,965,908,188 | 1,707,475,455 | 1,702,017,390 | 1,694,929,949 |
Przepływy pieniężne 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $664M | $673M | $644M | $685M | $640M | $546M | $519M | $477M | $406M | $310M | $292M | $246M | |
| Deferred Tax | $441M | $-7.96B | $-461M | $-659M | $-509M | $-108M | $-491M | $745M | $-890M | $-127M | $293M | $302M | |
| Amort. of Intangibles | $1.68B | $1.88B | $1.97B | $2.01B | $2.05B | $2.13B | $1.94B | $2.18B | $1.98B | $550M | $601M | $630M | |
| Restructuring | · | · | · | · | · | $36M | $66M | $28M | · | · | · | · | |
| Operating Cash Flow | $9.57B | $8.56B | $7.26B | $9.58B | $10.53B | $7.90B | $6.14B | $6.30B | $5.57B | $3.20B | $2.97B | $3.67B | |
| CapEx | $2.17B | $2.21B | $2.20B | $1.78B | $1.89B | $2.18B | $1.64B | $1.39B | $1.14B | $1.12B | $1.11B | $1.08B | |
| Investing Cash Flow | $-2.42B | $-2.34B | $-3.13B | $-1.74B | $-2.01B | $-2.21B | $-1.81B | $-1.36B | $-9.62B | $-248M | $406M | $-202M | |
| Debt Issued | · | · | · | · | $4M | $1.28B | $1.84B | $4.01B | $6.74B | $14.93B | $2.48B | · | |
| Net Debt Issued | · | · | · | · | $-44M | $-52M | $-1.60B | $-8.42B | $-1.91B | $14.92B | $2.43B | $-577M | |
| Stock Repurchased | $893M | $1.29B | $1.23B | $3.79B | $2.30B | $403M | $718M | $238M | $117M | $522M | $2.24B | $2.19B | |
| Net Stock Activity | $-893M | $-1.29B | $-1.23B | $-3.79B | $-2.30B | $-403M | $-718M | $-238M | $-117M | $-522M | $-2.24B | $-2.19B | |
| Dividends Paid | $4.12B | $3.84B | $3.56B | $3.31B | $3.20B | $2.56B | $2.27B | $1.97B | $1.85B | $1.54B | $1.44B | $1.34B | |
| Financing Cash Flow | $-6.31B | $-5.40B | $-7.09B | $-7.64B | $-5.49B | $-2.78B | $-4.29B | $-10.39B | $-5.28B | $11.15B | $-2.24B | $-2.74B | |
| Net Change in Cash | $906M | $720M | $-2.99B | $83M | $2.96B | $2.98B | $16M | $-5.56B | $-9.21B | $13.62B | $938M | $588M | |
| Taxes Paid | $1.93B | $1.72B | $1.48B | $1.86B | $1.94B | $970M | $930M | $740M | $570M | $620M | $631M | · | |
| Free Cash Flow | $7.39B | $6.35B | $5.06B | $7.80B | $8.65B | $5.72B | $4.50B | $4.91B | $4.43B | $2.08B | $1.86B | $2.60B | |
| Levered FCF | · | · | $4.51B | $7.34B | $8.19B | $5.23B | $3.89B | $4.23B | $4.29B | $1.76B | $1.72B | $2.50B |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% | 15.5% | 14.2% | 11.9% | 6.3% | 15.3% | 14.1% | 12.8% | |
| Net Margin | 14.7% | 31.9% | 14.3% | 15.9% | 16.4% | 13.0% | 11.6% | 7.7% | 1.7% | 6.7% | 21.7% | 11.3% | |
| Pretax Margin | 19.1% | 16.7% | 16.6% | 19.0% | 19.1% | 14.4% | 12.8% | 9.4% | 8.2% | 6.8% | 15.6% | 12.4% | |
| EBITDA Margin | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% | 15.5% | 14.2% | 11.9% | 6.3% | 15.3% | 14.1% | 12.8% | |
| ROA | 7.8% | 17.3% | 7.8% | 9.3% | 9.6% | 6.4% | 5.5% | 3.3% | 0.74% | 3.0% | 10.7% | 5.4% | |
| ROE | 13.1% | 31.1% | 15.2% | 19.1% | 20.6% | 14.1% | 12.0% | 7.7% | 1.8% | 6.7% | 20.7% | 9.8% | |
| ROIC | 9.5% | 21.1% | 10.4% | 13.1% | 13.5% | 9.4% | 8.3% | 5.9% | 0.46% | 5.6% | 7.8% | 6.0% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.7 | 1.6 | 1.6 | 1.8 | 1.7 | 1.4 | 1.6 | 2.3 | 4.0 | 1.5 | 1.4 | |
| Quick Ratio | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 | 1.1 | 0.9 | 1.0 | 1.7 | 3.3 | 1.0 | 0.8 | |
| Debt / Equity | 0.2 | 0.3 | 0.4 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.9 | 1.1 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.2 | 0.3 | 0.4 | 0.4 | 0.5 | 0.6 | 0.5 | 0.6 | 0.9 | 1.0 | 0.3 | 0.2 | |
| Interest Coverage | · | · | 10.2 | 15.0 | 15.8 | 9.8 | 6.8 | 4.4 | 1.9 | 7.4 | 17.6 | 17.3 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | |
| Inventory Turnover | 3.0 | 2.9 | 2.8 | 3.4 | 3.6 | 3.2 | 3.3 | 3.4 | 4.1 | 3.6 | 3.3 | 3.5 | |
| Receivables Turnover | 6.0 | 6.2 | 6.3 | 6.9 | 6.7 | 5.8 | 6.0 | 5.9 | 6.4 | 6.3 | 5.8 | 5.3 |
Stopy Wzrostu 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.7% | 4.6% | -8.1% | 1.3% | 24.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.51% | -0.88% | 5.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -51.3% | 134.4% | -16.6% | -0.76% | 57.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -1.7% | 24.7% | 9.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 8.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -51.3% | 134.2% | -17.4% | -1.9% | 57.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -2.0% | 23.8% | 8.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 7.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 10.0% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B | $27.39B | $20.85B | $20.41B | $20.25B | |
| Net Income TTM | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B | $477M | $1.40B | $4.42B | $2.28B | |
| Market Cap | $250.18B | $225.26B | $218.81B | $218.10B | $279.41B | $216.92B | $171.71B | $142.58B | $112.19B | $65.58B | · | · | |
| Enterprise Value | $254.17B | $231.41B | $226.21B | $224.70B | $287.21B | $228.52B | $185.71B | $158.06B | $130.51B | $68.82B | · | · | |
| P/E | 33.7 | 14.8 | 33.8 | 28.1 | 35.7 | 43.8 | 42.2 | 54.4 | 211.4 | 40.9 | 15.4 | 30.2 | |
| P/S | 5.6 | 5.4 | 5.5 | 5.0 | 6.5 | 6.3 | 5.4 | 4.7 | 4.1 | 3.1 | · | · | |
| P/B | 4.8 | 4.7 | 5.7 | 5.9 | 7.8 | 6.6 | 5.5 | 4.7 | 3.6 | 3.2 | · | · | |
| P / Tangible Book | 11.1 | 12.6 | 35.8 | 63.5 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 26.2 | 26.3 | 30.1 | 22.8 | 26.5 | 27.5 | 28.0 | 22.6 | 20.1 | 20.5 | · | · | |
| P / FCF | 33.8 | 35.5 | 43.3 | 27.9 | 32.3 | 37.9 | 38.2 | 29.1 | 25.3 | 31.5 | · | · | |
| EV / EBITDA | 31.6 | 33.9 | 34.9 | 26.9 | 34.1 | 42.7 | 41.0 | 43.3 | 75.6 | 21.6 | · | · | |
| EV / FCF | 34.4 | 36.4 | 44.7 | 28.8 | 33.2 | 39.9 | 41.3 | 32.2 | 29.4 | 33.1 | · | · | |
| EV / Revenue | 5.7 | 5.5 | 5.6 | 5.1 | 6.7 | 6.6 | 5.8 | 5.2 | 4.8 | 3.3 | · | · | |
| Dividend Yield | 1.7% | 1.7% | 1.6% | 1.5% | 1.1% | 1.2% | 1.3% | 1.4% | 1.7% | 2.4% | · | · | |
| Earnings Yield | 3.0% | 6.8% | 3.0% | 3.6% | 2.8% | 2.3% | 2.4% | 1.8% | 0.47% | 2.5% | 6.5% | 3.3% | |
| Payout Ratio | 63.1% | 28.6% | 62.1% | 47.7% | 45.3% | 57.0% | 61.6% | 83.4% | 387.6% | 109.9% | 32.6% | 58.8% | |
| Annual Payout | $4.12B | $3.84B | $3.56B | $3.31B | $3.20B | $2.56B | $2.27B | $1.97B | $1.85B | $1.54B | $1.44B | $1.34B |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.59B | $11.16B | $11.46B | $11.37B | $11.14B | $10.36B | $10.97B | $10.63B | $10.38B | $9.96B | $10.24B | $10.14B | $9.98B | $9.75B | $10.09B | $10.41B | |
| Cost of Revenue | $5.33B | $4.89B | $4.92B | $5.08B | $4.85B | $4.47B | $4.94B | $4.70B | $4.60B | $4.46B | $4.56B | $4.61B | $4.48B | $4.33B | $4.59B | $4.63B | |
| R&D Expense | $892M | $767M | $735M | $766M | $725M | $716M | $749M | $713M | $698M | $684M | $700M | $672M | $715M | $654M | $725M | $782M | |
| SG&A Expense | $4.03B | $3.74B | $3.13B | $3.05B | $3.09B | $3.06B | $2.91B | $2.90B | $2.94B | $2.96B | $2.72B | $2.72B | $2.74B | $2.76B | $2.97B | $2.73B | |
| Operating Expenses | $10.90B | $9.82B | $9.21B | $9.31B | $9.09B | $8.66B | $9.06B | $8.78B | $8.71B | $8.58B | $8.46B | $8.50B | $8.44B | $8.24B | $8.79B | $8.64B | |
| Operating Income | $1.69B | $1.34B | $2.25B | $2.06B | $2.05B | $1.69B | $1.91B | $1.86B | $1.67B | $1.39B | $1.78B | $1.65B | $1.54B | $1.51B | $1.30B | $1.77B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $141M | · | $166M | $159M | $153M | · | $141M | |
| Interest Income | $52M | $106M | $78M | $77M | $71M | $82M | $91M | $91M | $82M | $80M | $89M | $97M | $98M | $101M | $88M | $55M | |
| Other Non-op | $134M | $159M | $134M | $150M | $137M | $127M | $154M | $121M | $-10M | $111M | $109M | $83M | $176M | $111M | $68M | $93M | |
| Pretax Income | $1.52B | $1.45B | $2.36B | $2.18B | $2.15B | $1.78B | $2.03B | $1.94B | $1.61B | $1.44B | $1.79B | $1.67B | $1.64B | $1.56B | $1.32B | $1.76B | |
| Income Tax | $596M | $372M | $582M | $536M | $371M | $453M | $-7.20B | $294M | $305M | $211M | $201M | $235M | $261M | $244M | $287M | $323M | |
| Net Income | $928M | $1.08B | $1.78B | $1.64B | $1.78B | $1.32B | $9.23B | $1.65B | $1.30B | $1.23B | $1.59B | $1.44B | $1.38B | $1.32B | $1.03B | $1.44B | |
| EPS (Basic) | $0.53 | $0.62 | $1.01 | $0.94 | $1.02 | $0.76 | $5.29 | $0.94 | $0.74 | $0.70 | $0.92 | $0.82 | $0.79 | $0.75 | $0.59 | $0.82 | |
| EPS (Diluted) | $0.53 | $0.61 | $1.01 | $0.94 | $1.01 | $0.76 | $5.26 | $0.94 | $0.74 | $0.70 | $0.91 | $0.82 | $0.78 | $0.75 | $0.59 | $0.81 | |
| Shares (Basic) | 1,740,420,000 | 1,742,480,000 | -3,483,785,000 | 1,742,142,000 | 1,743,437,000 | 1,739,206,000 | -3,482,709,000 | 1,739,466,000 | 1,743,040,000 | 1,740,203,000 | -3,480,797,000 | 1,738,700,000 | 1,740,359,000 | 1,741,738,000 | -3,515,744,000 | 1,752,968,000 | |
| Shares (Diluted) | 1,742,981,000 | 1,747,073,000 | -3,499,416,000 | 1,749,361,000 | 1,750,835,000 | 1,747,220,000 | -3,500,402,000 | 1,747,597,000 | 1,751,153,000 | 1,749,652,000 | -3,501,252,000 | 1,748,289,000 | 1,750,248,000 | 1,751,715,000 | -3,539,658,000 | 1,763,653,000 | |
| EBITDA | $1.69B | $1.34B | · | $2.06B | $2.05B | $1.69B | · | $1.86B | $1.67B | $1.39B | · | $1.65B | $1.54B | $1.51B | · | $1.77B |
Bilans 23
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.10B | $6.80B | $8.52B | $7.51B | $6.95B | $6.53B | $7.62B | $7.56B | $6.99B | $6.28B | · | $6.71B | $7.83B | $9.16B | · | $9.59B | |
| Short-term Investments | $499M | $492M | $417M | $222M | $331M | $312M | $351M | $230M | $232M | $367M | · | $338M | $320M | $371M | · | $313M | |
| Receivables | $8.60B | $8.21B | $7.93B | $8.14B | $7.97B | $7.33B | $6.92B | $7.05B | $6.85B | $6.61B | · | $6.50B | $6.17B | $6.02B | · | $6.41B | |
| Inventory | $7.32B | $6.99B | $6.49B | $6.71B | $6.95B | $6.64B | $6.19B | $6.81B | $6.81B | $6.83B | · | $6.65B | $6.87B | $6.67B | · | $5.73B | |
| Current Assets | $24.52B | $25.51B | $26.00B | $24.84B | $24.47B | $23.15B | $23.66B | $23.80B | $23.12B | $22.38B | · | $22.66B | $23.50B | $24.38B | · | $24.84B | |
| PP&E (Net) | $12.81B | $12.38B | $11.82B | $11.50B | $11.39B | $10.93B | $10.66B | $10.62B | $10.23B | $10.11B | · | $9.55B | $9.45B | $9.28B | · | $8.69B | |
| PP&E (Gross) | $26.47B | $25.74B | $25.22B | $24.82B | $24.47B | $23.42B | $22.74B | $22.86B | $22.06B | $22.05B | · | $21.11B | $20.93B | $20.61B | · | $19.31B | |
| Accum. Depreciation | $13.66B | $13.36B | $13.41B | $13.31B | $13.08B | $12.49B | $12.08B | $12.24B | $11.83B | $11.95B | · | $11.56B | $11.48B | $11.32B | · | $10.62B | |
| Goodwill | $35.24B | $35.22B | $24.04B | $23.97B | $23.95B | $23.36B | $23.11B | $23.66B | $23.31B | $23.38B | · | $23.28B | $23.26B | $22.93B | · | $22.28B | |
| Intangibles | $17.21B | $17.88B | $5.53B | $5.60B | $5.92B | $6.26B | $6.65B | $7.35B | $7.83B | $8.30B | · | $9.28B | $9.83B | $10.01B | · | $10.85B | |
| Total Assets | $109.22B | $110.43B | $86.71B | $84.18B | $84.00B | $81.45B | $81.41B | $74.36B | $73.02B | $72.47B | · | $72.09B | $73.35B | $73.79B | · | $72.80B | |
| Current Liabilities | $17.81B | $18.38B | $16.50B | $14.58B | $13.44B | $13.00B | $14.16B | $14.90B | $13.76B | $14.02B | · | $13.04B | $14.35B | $14.53B | · | $13.37B | |
| Capital Leases | · | · | $931M | · | · | · | $896M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $2.54B | · | · | · | $2.59B | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | $32.61B | $34.05B | $12.93B | $12.94B | $13.44B | $13.24B | $14.12B | $14.98B | $14.75B | $14.59B | · | $15.53B | $16.85B | $16.90B | · | $16.41B | |
| Total Debt | $32.61B | $34.05B | · | $12.94B | $13.44B | $13.24B | · | $14.98B | $14.75B | $14.59B | · | $15.53B | $16.85B | $16.90B | · | $16.41B | |
| Common Stock | $25.50B | $25.35B | $25.53B | $25.41B | $25.28B | $25.12B | $25.15B | $25.02B | $24.86B | $24.73B | · | $24.73B | $24.61B | $24.49B | · | $24.56B | |
| Retained Earnings | $49.79B | $49.96B | $49.78B | $49.10B | $48.47B | $47.72B | $47.26B | $39.06B | $38.35B | $38.01B | · | $36.92B | $36.35B | $35.87B | · | $35.12B | |
| Treasury Stock | $17.97B | $16.93B | $17.18B | $16.88B | $16.61B | $16.61B | $16.84B | $16.48B | $15.76B | $15.76B | · | $15.69B | $15.72B | $15.31B | · | $14.55B | |
| AOCI | $-6.21B | $-6.31B | $-6.00B | $-6.68B | $-6.58B | $-7.42B | $-7.91B | $-7.80B | $-8.13B | $-8.17B | $-7.84B | $-8.48B | $-8.07B | $-8.04B | $-8.05B | $-9.45B | |
| Stockholders' Equity | $51.11B | $52.06B | $52.13B | $50.95B | $50.56B | $48.81B | $47.66B | $39.80B | $39.32B | $38.81B | · | $37.48B | $37.17B | $37.01B | · | $35.67B | |
| Liabilities + Equity | $109.22B | $110.43B | $86.71B | $84.18B | $84.00B | $81.45B | $81.41B | $74.36B | $73.02B | $72.47B | · | $72.09B | $73.35B | $73.79B | · | $72.80B | |
| Shares Outstanding | 1,998,291,279 | 1,998,233,756 | 1,996,795,525 | 1,996,743,794 | 1,996,448,469 | 1,995,858,606 | 1,991,472,630 | 1,991,051,414 | 1,990,029,292 | 1,989,789,999 | 1,987,883,852 | 1,987,305,154 | 1,987,181,491 | 1,986,904,170 | 1,986,519,278 | 1,985,919,440 |
Przepływy pieniężne 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $168M | $317M | $113M | $120M | $142M | $289M | $111M | $117M | $141M | $304M | $114M | $117M | $132M | $281M | $115M | $123M | |
| Amort. of Intangibles | $658M | $422M | $422M | $420M | $420M | $420M | $465M | $470M | $471M | $472M | $481M | $496M | $498M | $491M | $496M | $498M | |
| Operating Cash Flow | $2.49B | $1.31B | $3.31B | $2.79B | $2.05B | $1.42B | $2.87B | $2.71B | $1.96B | $1.02B | $3.04B | $1.88B | $1.20B | $1.14B | $2.33B | $2.78B | |
| CapEx | $497M | $399M | $689M | $496M | $502M | $484M | $720M | $556M | $533M | $398M | $755M | $560M | $507M | $380M | $610M | $467M | |
| Investing Cash Flow | $-673M | $-20.32B | $-913M | $-457M | $-582M | $-470M | $-866M | $-594M | $-453M | $-425M | $-824M | $-634M | $-1.21B | $-462M | $-632M | $-484M | |
| Debt Issued | $-33M | $19.86B | · | $0 | $2M | $1M | · | $1M | $221M | $0 | · | $0 | · | · | · | $1M | |
| Net Debt Issued | · | $18.44B | · | · | · | $-1.00B | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Repurchased | $1.04B | $180M | $302M | $305M | $6M | $280M | $315M | $751M | $3M | $226M | $259M | $2M | $426M | $540M | $685M | $798M | |
| Net Stock Activity | · | $-180M | · | · | · | $-280M | · | · | · | $-226M | · | · | · | $-540M | · | · | |
| Dividends Paid | $1.10B | $1.10B | $1.03B | $1.03B | $1.03B | $1.03B | $958M | $960M | $961M | $957M | $888M | $888M | $890M | $890M | $823M | $826M | |
| Financing Cash Flow | $-3.52B | $17.31B | $-1.40B | $-1.76B | $-1.10B | $-2.06B | $-1.86B | $-1.58B | $-791M | $-1.18B | $-2.05B | $-2.34B | $-1.29B | $-1.41B | $-1.46B | $-1.54B | |
| Net Change in Cash | $-1.70B | $-1.72B | $1.01B | $560M | $419M | $-1.08B | $58M | $571M | $703M | $-612M | $187M | $-1.13B | $-1.33B | $-721M | $288M | $657M | |
| Free Cash Flow | · | $916M | · | · | · | $933M | · | · | · | $627M | · | · | · | $763M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $507M | · | · | · | $634M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.4% | 12.0% | · | 18.1% | 18.4% | 16.3% | · | 17.5% | 16.1% | 13.9% | · | 16.2% | 15.4% | 15.5% | · | 17.0% | |
| Net Margin | 7.4% | 9.7% | · | 14.5% | 16.0% | 12.8% | · | 15.5% | 12.6% | 12.3% | · | 14.2% | 13.8% | 13.5% | · | 13.8% | |
| Pretax Margin | 12.1% | 13.0% | · | 19.2% | 19.3% | 17.2% | · | 18.2% | 15.5% | 14.4% | · | 16.5% | 16.4% | 16.0% | · | 16.9% | |
| EBITDA Margin | 13.4% | 12.0% | · | 18.1% | 18.4% | 16.3% | · | 17.5% | 16.1% | 13.9% | · | 16.2% | 15.4% | 15.5% | · | 17.0% | |
| ROA | 0.96% | 1.1% | · | 2.1% | 2.3% | 1.7% | · | 2.2% | 1.8% | 1.7% | · | 2.0% | 1.9% | 1.8% | · | 2.0% | |
| ROE | 1.8% | 2.1% | · | 3.6% | 4.0% | 3.0% | · | 4.3% | 3.4% | 3.2% | · | 3.9% | 3.7% | 3.6% | · | 4.1% | |
| ROIC | 1.2% | 1.2% | · | 2.4% | 2.6% | 2.0% | · | 2.9% | 2.5% | 2.2% | · | 2.7% | 2.4% | 2.4% | · | 2.8% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.7 | 1.8 | 1.8 | · | 1.6 | 1.7 | 1.6 | · | 1.7 | 1.6 | 1.7 | · | 1.9 | |
| Quick Ratio | 0.8 | 0.8 | · | 1.1 | 1.1 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 | 1.0 | 1.1 | · | 1.2 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.6 | · | 0.2 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 9.8 | · | 9.9 | 9.7 | 9.9 | · | 12.6 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.8 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.6 | 1.5 | 1.5 | · | 1.6 |
Wycena (TTM) 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $46.27B | $44.03B | · | $43.50B | $42.51B | $41.33B | · | $41.12B | $40.46B | $39.83B | · | $40.28B | $41.39B | $43.31B | · | $44.49B | |
| Net Income TTM | $5.43B | $5.83B | · | $6.39B | $6.05B | $5.50B | · | $5.61B | $5.34B | $5.35B | · | $5.56B | $6.15B | $7.22B | · | $8.00B | |
| Market Cap | $181.32B | $205.16B | · | $267.44B | $271.54B | $264.75B | · | $227.00B | $206.78B | $226.16B | · | $192.47B | $216.64B | $201.19B | · | $192.16B | |
| Enterprise Value | $208.33B | $231.91B | · | $272.65B | $277.69B | $271.15B | · | $234.19B | $214.32B | $234.09B | · | $200.95B | $225.33B | $208.56B | · | $198.66B | |
| P/E | 29.4 | 30.9 | · | 36.7 | 39.4 | 42.2 | · | 35.6 | 34.2 | 37.3 | · | 30.6 | 31.3 | 24.9 | · | 21.6 | |
| P/S | 3.9 | 4.7 | · | 6.1 | 6.4 | 6.4 | · | 5.5 | 5.1 | 5.7 | · | 4.8 | 5.2 | 4.6 | · | 4.3 | |
| P/B | 3.5 | 3.9 | · | 5.2 | 5.4 | 5.4 | · | 5.7 | 5.3 | 5.8 | · | 5.1 | 5.8 | 5.4 | · | 5.4 | |
| P / Tangible Book | · | · | · | 12.5 | 13.1 | 13.8 | · | 25.8 | 25.3 | 31.7 | · | 39.1 | 53.1 | 49.3 | · | 75.6 | |
| P / Cash Flow | · | 156.0 | · | · | · | 186.8 | · | · | · | 220.6 | · | · | · | 176.0 | · | · | |
| P / FCF | · | 224.0 | · | · | · | 283.8 | · | · | · | 360.7 | · | · | · | 263.7 | · | · | |
| EV / EBITDA | 123.1 | 172.4 | · | 132.5 | 135.3 | 160.2 | · | 126.0 | 128.4 | 168.9 | · | 122.0 | 146.1 | 138.2 | · | 112.2 | |
| EV / FCF | · | 253.2 | · | · | · | 290.6 | · | · | · | 373.4 | · | · | · | 273.3 | · | · | |
| EV / Revenue | 4.5 | 5.3 | · | 6.3 | 6.5 | 6.6 | · | 5.7 | 5.3 | 5.9 | · | 5.0 | 5.4 | 4.8 | · | 4.5 | |
| Earnings Yield | 3.4% | 3.2% | · | 2.7% | 2.5% | 2.4% | · | 2.8% | 2.9% | 2.7% | · | 3.3% | 3.2% | 4.0% | · | 4.6% | |
| Payout Ratio | · | 102.0% | · | · | · | 77.4% | · | · | · | 78.1% | · | · | · | 67.5% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B |
| Marża Operacyjna % | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% |
| Zysk netto | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B |
| Rozwodniony EPS | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.2 | 0.3 | 0.4 | 0.5 | 0.5 |
| Wskaźnik bieżący | 1.6 | 1.7 | 1.6 | 1.6 | 1.8 |
| Wskaźnik Szybkości | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $7.39B | $6.35B | $5.06B | $7.80B | $8.65B |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- Abbott raises 2026 profit forecast on strength in diagnostics, heart devices
- Why Abbott Stock Jumped Today
- Is Abbott (ABT) the Best Longevity Stock to Buy Now?
- This is Why Abbott Laboratories (ABT) is One of the Best Deep Value Stock to Invest In
- 2 akcje dywidendowe do kupienia i trzymania na zawsze
- Akcje Abbott Trading po 52-tygodniowych minimach, ale insiderzy pochłaniają akcje tej spółki dywidendowej z segmentu blue-chip
- Chcesz niezawodnych dochodów z dywidend w maju? Te 2 akcje je zapewniają
- Stopa dywidendy tego Króla Dywidend nie była tak wysoka od dekady. Czy warto go kupić?
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 3 307 emitentów · $77.5B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 167 (-58 vs poprzedni kw.) | 264 (-26 vs poprzedni kw.) | 1 074 (-57 vs poprzedni kw.) | 1 358 (-40 vs poprzedni kw.) | -26.3M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $10 321 765 196 | 113 750 994 | 13,32% | Akcje |
| STATE STREET CORP | $7 343 246 473 | 80 926 234 | 9,48% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4 447 881 161 | 49 017 866 | 5,74% | Akcje |
| Capital Research Global Investors | $3 349 205 208 | 36 908 990 | 4,32% | Akcje |
| Capital International Investors | $3 146 147 651 | 34 654 113 | 4,06% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $3 021 806 516 | 33 484 908 | 3,90% | Akcje |
| NORGES BANK | $2 119 224 624 | 23 354 911 | 2,73% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $988 809 932 | 10 897 178 | 1,28% | Akcje |
| FLOSSBACH VON STORCH SE | $902 938 133 | 9 950 828 | 1,17% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $887 350 453 | 9 779 044 | 1,14% | Akcje |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $873 572 128 | 9 627 200 | 1,13% | Akcje |
| Grantham, Mayo, Van Otterloo & Co. LLC | $797 974 712 | 8 794 077 | 1,03% | Akcje |
| JANUS HENDERSON GROUP PLC | $780 800 730 | 7 604 955 | 1,01% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $737 381 823 | 8 126 315 | 0,95% | Akcje |
| CITADEL ADVISORS LLC | $732 793 646 | 8 075 751 | 0,95% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $724 904 438 | 7 988 808 | 0,94% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $694 247 236 | 7 650 948 | 0,90% | Akcje |
| GOLDMAN SACHS GROUP INC | $579 394 142 | 6 385 212 | 0,75% | Akcje |
| BlackRock, Inc. | $551 881 406 | 6 082 008 | 0,71% | Akcje |
| AMERIPRISE FINANCIAL INC | $547 727 798 | 6 035 539 | 0,71% | Akcje |
| BANK OF AMERICA CORP /DE/ | $535 831 639 | 5 905 132 | 0,69% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $487 309 824 | 5 370 397 | 0,63% | Akcje |
| FMR LLC | $477 936 254 | 5 267 096 | 0,62% | Akcje |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $447 962 873 | 4 936 774 | 0,58% | Akcje |
| Swiss National Bank | $445 749 361 | 4 912 380 | 0,58% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $390 471 098 | 4 303 186 | 0,50% | Akcje |
| National Pension Service | $381 876 296 | 4 208 467 | 0,49% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $359 002 790 | 3 956 395 | 0,46% | Akcje |
| Legal & General Group Plc | $356 621 537 | 3 930 147 | 0,46% | Akcje |
| Vanguard Global Advisers, LLC | $356 401 041 | 3 927 717 | 0,46% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $356 221 103 | 3 925 734 | 0,46% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $355 855 239 | 3 921 702 | 0,46% | Akcje |
| VANGUARD GROUP INC | $352 398 046 | 2 812 659 | 0,45% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $326 663 456 | 3 599 994 | 0,42% | Akcje |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $324 048 420 | 3 571 175 | 0,42% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $307 912 464 | 2 999 050 | 0,40% | Akcje |
| UBS Group AG | $302 485 873 | 3 333 545 | 0,39% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $295 969 379 | 3 261 730 | 0,38% | Akcje |
| Assenagon Asset Management S.A. | $292 053 223 | 3 218 572 | 0,38% | Akcje |
| JARISLOWSKY, FRASER Ltd | $289 054 440 | 2 158 089 | 0,37% | Akcje |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | $283 562 500 | 3 125 000 | 0,37% | Akcje |
| Rathbones Group PLC | $279 003 540 | 3 074 758 | 0,36% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $274 648 102 | 2 675 057 | 0,35% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $262 660 558 | 2 558 299 | 0,34% | Akcje |
| STOREBRAND ASSET MANAGEMENT AS | $259 462 863 | 2 859 410 | 0,33% | Akcje |
| PNC Financial Services Group, Inc. | $257 810 942 | 2 841 205 | 0,33% | Akcje |
| RHUMBLINE ADVISERS | $255 936 973 | 2 820 543 | 0,33% | Akcje |
| UBS Group AG | $250 750 916 | 2 763 400 | 0,32% | Opcja sprzedaży |
| RAYMOND JAMES FINANCIAL INC | $245 980 061 | 2 710 823 | 0,32% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $239 769 108 | 2 642 375 | 0,31% | Akcje |
| 1832 Asset Management L.P. | $237 351 068 | 2 615 727 | 0,31% | Akcje |
| CITADEL ADVISORS LLC | $234 272 532 | 2 581 800 | 0,30% | Opcja kupna |
| CANADA PENSION PLAN INVESTMENT BOARD | $230 891 469 | 2 544 539 | 0,30% | Akcje |
| Holocene Advisors, LP | $226 003 396 | 2 490 670 | 0,29% | Akcje |
| Ninety One UK Ltd | $225 389 076 | 2 483 900 | 0,29% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $223 999 839 | 2 467 027 | 0,29% | Akcje |
| Ensign Peak Advisors, Inc | $216 085 151 | 2 381 366 | 0,28% | Akcje |
| JANE STREET GROUP, LLC | $213 973 994 | 2 358 100 | 0,28% | Opcja kupna |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $211 616 115 | 2 332 115 | 0,27% | Akcje |
| LPL Financial LLC | $205 718 613 | 2 267 122 | 0,27% | Akcje |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $201 807 847 | 2 224 023 | 0,26% | Akcje |
| BARCLAYS PLC | $200 112 461 | 2 205 339 | 0,26% | Akcje |
| Qube Research & Technologies Ltd | $194 357 367 | 2 141 915 | 0,25% | Akcje |
| California Public Employees Retirement System | $194 024 624 | 2 138 248 | 0,25% | Akcje |
| Nuveen Asset Management, LLC | $192 921 092 | 1 705 606 | 0,25% | Akcje |
| PeakShares LLC | $184 202 000 | 2 030 | 0,24% | Akcje |
| Fayez Sarofim & Co | $183 924 904 | 2 026 944 | 0,24% | Akcje |
| ProShare Advisors LLC | $182 849 174 | 2 015 089 | 0,24% | Akcje |
| Mirae Asset Global Investments Co., Ltd. | $171 498 419 | 1 889 998 | 0,22% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $171 110 051 | 1 885 718 | 0,22% | Akcje |
| US BANCORP \DE\ | $169 625 636 | 1 869 359 | 0,22% | Akcje |
| DAVENPORT & Co LLC | $166 731 901 | 1 827 013 | 0,22% | Akcje |
| Nuveen, LLC | $165 441 322 | 1 823 246 | 0,21% | Akcje |
| Focus Partners Wealth | $159 171 295 | 1 753 727 | 0,21% | Akcje |
| LOCUST WOOD CAPITAL ADVISERS, LLC | $156 227 543 | 1 721 705 | 0,20% | Akcje |
| FIFTH THIRD BANCORP | $155 739 304 | 1 716 325 | 0,20% | Akcje |
| Alecta Tjanstepension Omsesidigt | $145 922 256 | 1 609 200 | 0,19% | Akcje |
| Hudson Bay Capital Management LP | $145 184 000 | 1 600 000 | 0,19% | Akcje |
| Mizuho Markets Cayman LP | $144 086 409 | 1 587 904 | 0,19% | Akcje |
| HighTower Advisors, LLC | $143 884 700 | 1 585 681 | 0,19% | Akcje |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | $141 332 725 | 1 557 555 | 0,18% | Akcje |
| Point72 Asset Management, L.P. | $140 822 037 | 1 551 929 | 0,18% | Akcje |
| MACKENZIE FINANCIAL CORP | $140 782 112 | 1 551 489 | 0,18% | Akcje |
| GOLDMAN SACHS GROUP INC | $139 367 566 | 1 535 900 | 0,18% | Opcja kupna |
| AVIVA PLC | $138 734 382 | 1 528 922 | 0,18% | Akcje |
| Hudson Bay Capital Management LP | $136 110 000 | 1 500 000 | 0,18% | Opcja sprzedaży |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $134 754 435 | 1 485 061 | 0,17% | Akcje |
| EVERETT HARRIS & CO /CA/ | $131 785 524 | 1 452 342 | 0,17% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $130 414 419 | 1 432 081 | 0,17% | Akcje |
| TD Asset Management Inc | $129 183 362 | 1 423 665 | 0,17% | Akcje |
| Vestal Point Capital, LP | $127 036 000 | 1 400 000 | 0,16% | Akcje |
| Bank Julius Baer & Co. Ltd, Zurich | $126 054 316 | 1 387 458 | 0,16% | Akcje |
| Freestone Grove Partners LP | $124 572 046 | 1 372 846 | 0,16% | Akcje |
| Public Sector Pension Investment Board | $124 551 992 | 1 372 625 | 0,16% | Akcje |
| Eurizon Capital SGR S.p.A. | $121 802 182 | 1 335 277 | 0,16% | Akcje |
| M&G PLC | $120 614 949 | 1 325 439 | 0,16% | Akcje |
| ING GROEP NV | $119 814 457 | 1 320 415 | 0,15% | Akcje |
| MARSHALL WACE, LLP | $119 044 891 | 1 311 934 | 0,15% | Akcje |
| Baird Financial Group, Inc. | $116 820 060 | 1 287 415 | 0,15% | Akcje |
| PRUDENTIAL FINANCIAL INC | $115 655 480 | 1 274 581 | 0,15% | Akcje |
Insiderzy spółki 110 insiderów · 75 dyrektorzy generalni · 32 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert B Ford | CHAIRMAN AND CEO | 28 lutego 2025 F | 253 305 | 0 | 0 | $0 |
| Philip P Boudreau | EVP AND CFO | 1 września 2025 F | 50 616 | 0 | 0 | $0 |
| Brian B Yoor | Executive Vice President & CFO | 28 lutego 2020 F | 114 099 | 0 | 0 | $0 |
| Jeffrey M Leiden | President and COO | 24 marca 2006 D | 209 401 | 0 | 0 | $0 |
| Elizabeth C. Cushman | EVP, GC AND SECRETARY | 27 czerwca 2026 F | 38 013 | 0 | 0 | $0 |
| John A. Mccoy JR. | VICE PRESIDENT AND CONTROLLER | 1 września 2025 F | 20 982 | 0 | 0 | $0 |
| Lisa D Earnhardt | EVP AND GROUP PRESIDENT | 7 marca 2025 M | 71 928 | 0 | 0 | $0 |
| Eric Shroff | Senior Vice President | 3 marca 2025 S | 31 970 | 0 | 0 | $0 |
| Mary K Moreland | EXECUTIVE VICE PRESIDENT | 3 marca 2025 S | 95 583 | 0 | 0 | $0 |
| Andrea F Wainer | RETIRED EVP | 3 marca 2025 S | 74 381 | 0 | 0 | $0 |
| Daniel Gesua Sive Salvadori | EVP AND GROUP PRESIDENT | 28 lutego 2025 F | 133 769 | 0 | 0 | $0 |
| Hubert L Allen | EXECUTIVE VICE PRESIDENT, GC | 28 lutego 2025 F | 191 899 | 0 | 0 | $0 |
| Robert E Funck | EXECUTIVE VICE PRESIDENT | 10 maja 2024 M | 211 341 | 0 | 0 | $0 |
| Julie L. Tyler | SENIOR VICE PRESIDENT | 1 marca 2023 S | 39 162 | 0 | 0 | $0 |
| Gregory A Ahlberg | SENIOR VICE PRESIDENT | 1 marca 2023 S | 38 420 | 0 | 0 | $0 |
| John F Ginascol | EXECUTIVE VICE PRESIDENT | 1 marca 2023 S | 118 380 | 0 | 0 | $0 |
| Joseph J Manning | EXECUTIVE VICE PRESIDENT | 1 marca 2023 S | 62 323 | 0 | 0 | $0 |
| Jared Watkin | SENIOR VICE PRESIDENT | 1 marca 2023 S | 71 366 | 0 | 0 | $0 |
| Randel William Woodgrift | SENIOR VICE PRESIDENT | 1 marca 2023 S | 52 203 | 0 | 0 | $0 |
| DALE MICHAEL D | SENIOR VICE PRESIDENT | 1 marca 2023 S | 45 133 | 0 | 0 | $0 |
| Fernando Mateus | SENIOR VICE PRESIDENT | 28 lutego 2023 F | 22 857 | 0 | 0 | $0 |
| Christopher J. Calamari | SENIOR VICE PRESIDENT | 28 lutego 2023 F | 32 822 | 0 | 0 | $0 |
| Sammy Karam | SENIOR VICE PRESIDENT | 28 lutego 2023 F | 38 092 | 0 | 0 | $0 |
| Alejandro D Wellisch | SENIOR VICE PRESIDENT | 28 lutego 2023 F | 46 752 | 0 | 0 | $0 |
| Michael J Pederson | SENIOR VICE PRESIDENT | 28 lutego 2023 F | 63 156 | 0 | 0 | $0 |
| John M Capek | EXECUTIVE VICE PRESIDENT | 28 lutego 2023 F | 339 443 | 0 | 0 | $0 |
| Andrew H Lane | EXECUTIVE VICE PRESIDENT | 15 listopada 2021 S | 76 087 | 0 | 0 | $0 |
| Miles D White | EXECUTIVE CHAIRMAN | 12 listopada 2021 G | 3 092 852 | 0 | 0 | $0 |
| Roger Bird | SENIOR VICE PRESIDENT | 27 kwietnia 2021 S | 51 083 | 0 | 0 | $0 |
| Christopher J Scoggins | SENIOR VICE PRESIDENT | 1 kwietnia 2021 F | 46 121 | 0 | 0 | $0 |
| Charles Brynelsen | SENIOR VICE PRESIDENT | 1 marca 2021 S | 43 550 | 0 | 0 | $0 |
| Jaime Contreras | Senior Vice President | 21 kwietnia 2020 M | 62 205 | 0 | 0 | $0 |
| Brian J Blaser | Executive Vice President | 23 maja 2019 M | 130 745 | 0 | 0 | $0 |
| Stephen R Fussell | Executive Vice President | 23 kwietnia 2019 M | 169 935 | 0 | 0 | $0 |
| Sharon J Bracken | Senior Vice President | 31 marca 2019 D | 5 936 | 0 | 0 | $0 |
| Sean Shrimpton | Senior Vice President | 31 grudnia 2018 F | 16 165 | 0 | 0 | $0 |
| Eric S Fain | Senior Vice President | 21 lipca 2017 D | 493 961 | 0 | 0 | $0 |
| Michael T Rousseau | Pres., Cardiovas. & Neuromod. | 7 lipca 2017 F | 183 116 | 0 | 0 | $0 |
| Heather L Mason | Executive Vice President | 1 lipca 2017 F | 59 064 | 0 | 0 | $0 |
| Michael J Warmuth | Executive Vice President | 1 marca 2017 S | 56 508 | 0 | 0 | $0 |
| Jean-Yves Pavee | Senior Vice President | 1 lipca 2016 F | 36 861 | 0 | 0 | $0 |
| Richard W Ashley | Executive Vice President | 29 lutego 2016 S | 354 517 | 0 | 0 | $0 |
| Thomas G Frinzi | Senior Vice President | 19 lutego 2016 A | 31 921 | 0 | 0 | $0 |
| Charles D Foltz | Senior Vice President | 1 kwietnia 2015 F | 93 333 | 0 | 0 | $0 |
| Scott J. White | Senior Vice President | 26 marca 2015 M | 95 719 | 0 | 0 | $0 |
| Georges H. Devos | Senior Vice President | 27 lutego 2015 A | 12 129 | 0 | 0 | $0 |
| Murthy V Simhambhatla | Senior Vice President | 27 lutego 2015 F | 57 575 | 0 | 0 | $0 |
| John C Landgraf | Executive Vice President | 27 lutego 2015 F | 108 972 | 0 | 0 | $0 |
| Katherine C. Doyle | Senior Vice President | 15 kwietnia 2014 S | 43 474 | 0 | 0 | $0 |
| David A. Forrest | Senior Vice President | 17 września 2013 F | 42 013 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 11 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| [Entities Only] Abbott Laboratories (, Abbott Products, Abbott Investments Luxembourg S.à r.l. ×6 zgłoszenia | 24 marca 2017 | — | Pierwotne zgłoszenie | — | SEC |
| Abbott Laboratories, Amber Acquisition Inc. ×13 zgłoszenia | 21 kwietnia 2010 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| Abbott Laboratories IRS Identification No. ×11 zgłoszenia | 16 grudnia 2004 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 22 stycznia 2004 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| S. OR | 8 sierpnia 2002 | — | Pierwotne zgłoszenie | — | SEC |
| Abbott Laboratories ( | 7 marca 2002 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 1 listopada 2001 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| Niezgłoszona osoba raportująca | 24 maja 2001 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 17 kwietnia 2001 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 7 marca 2001 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 16 lutego 2001 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 227 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHI · iShares Trust | 19,02% | 5 737 319 SH | 21 sierpnia 2026 | Dziennie |
| PJP · Invesco Exchange-Traded Fund Trust | 5,77% | 267 267 SH | 21 sierpnia 2026 | Dziennie |
| CTIF · EA Series Trust | 3,42% | 71 816 NS | 29 maja 2026 | N-PORT |
| IYH · iShares Trust | 3,05% | 1 033 684 SH | 21 sierpnia 2026 | Dziennie |
| SCHD · SCHWAB STRATEGIC TRUST | 2,96% | 32 820 222 NS | 31 maja 2026 | N-PORT |
| CWS · AdvisorShares Trust | 2,95% | 43 046 NS | 30 czerwca 2026 | N-PORT |
| HRTS · Tema ETF Trust | 2,61% | 15 809 NS | 31 maja 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 2,55% | 801 594 NS | 30 kwietnia 2026 | N-PORT |
| IXJ · iShares Trust | 2,40% | 915 890 SH | 21 sierpnia 2026 | Dziennie |
| HDV · iShares Trust | 2,39% | 3 218 623 SH | 21 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 2,33% | 5 235 711 SH | 19 sierpnia 2026 | Dziennie |
| QLTY · GMO ETF Trust | 2,29% | 1 204 586 NS | 31 maja 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 2,28% | 34 673 NS | 30 kwietnia 2026 | N-PORT |
| RXL · ProShares Trust | 2,15% | 18 132 NS | 31 maja 2026 | N-PORT |
| QUSA · Tidal Trust III | 2,14% | 4 173 NS | 30 kwietnia 2026 | N-PORT |
| FDIV · EA Series Trust | 1,95% | 15 623 NS | 30 kwietnia 2026 | N-PORT |
| PRVS · Parnassus Funds II | 1,94% | 5 401 NS | 30 czerwca 2026 | N-PORT |
| OUSA · ALPS ETF Trust | 1,92% | 166 396 NS | 31 maja 2026 | N-PORT |
| MDEV · First Trust Exchange-Traded Fund VI | 1,85% | 392 NS | 30 czerwca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,85% | 133 006 SH | 21 sierpnia 2026 | Dziennie |
| JGRW · Trust for Professional Managers | 1,77% | 19 858 NS | 31 maja 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 1,48% | 7 452 NS | 30 kwietnia 2026 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1,42% | 528 786 NS | 30 kwietnia 2026 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 1,41% | 78 110 NS | 31 maja 2026 | N-PORT |
| SPXD · DBX ETF Trust | 1,37% | 1 082 NS | 31 maja 2026 | N-PORT |
| NOBL · ProShares Trust | 1,35% | 1 749 432 NS | 31 maja 2026 | N-PORT |
| ANEW · ProShares Trust | 1,32% | 1 196 NS | 31 maja 2026 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 1,24% | 50 554 NS | 31 maja 2026 | N-PORT |
| TMDV · ProShares Trust | 1,23% | 633 NS | 31 maja 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,21% | 296 845 SH | 21 sierpnia 2026 | Dziennie |
| DGRO · iShares Trust | 1,17% | 4 472 407 SH | 21 sierpnia 2026 | Dziennie |
| SHRY · First Trust Exchange-Traded Fund VI | 1,07% | 1 770 NS | 30 czerwca 2026 | N-PORT |
| DAK · EA Series Trust | 1,05% | 5 270 NS | 29 maja 2026 | N-PORT |
| SNPV · DBX ETF Trust | 1,01% | 27 271 NS | 29 maja 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 1,01% | 4 283 NS | 30 kwietnia 2026 | N-PORT |
| CGCV · Capital Group Conservative Equity E… | 1,00% | 205 102 NS | 31 maja 2026 | N-PORT |
| RDVI · First Trust Exchange-Traded Fund IV | 0,90% | 304 156 NS | 30 kwietnia 2026 | N-PORT |
| BSCQ · Invesco Exchange-Traded Self-Indexe… | 0,85% | 29 472 000 | 21 sierpnia 2026 | Dziennie |
| WBIG · Absolute Shares Trust | 0,82% | 2 495 NS | 30 czerwca 2026 | N-PORT |
| BIGY · Tidal Trust II | 0,82% | 2 364 NS | 30 kwietnia 2026 | N-PORT |
| USMV · iShares Trust | 0,79% | 1 672 210 SH | 21 sierpnia 2026 | Dziennie |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,77% | 73 722 NS | 30 kwietnia 2026 | N-PORT |
| CGDV · Capital Group Dividend Value ETF | 0,75% | 3 098 502 NS | 31 maja 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,75% | 1 094 793 SH | 19 sierpnia 2026 | Dziennie |
| DIVB · iShares Trust | 0,74% | 123 321 SH | 21 sierpnia 2026 | Dziennie |
| IWX · iShares Trust | 0,73% | 255 571 SH | 21 sierpnia 2026 | Dziennie |
| CAPE · DoubleLine ETF Trust | 0,72% | 18 972 NS | 30 czerwca 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,72% | 8 721 NS | 30 kwietnia 2026 | N-PORT |
| PFM · Invesco Exchange-Traded Fund Trust | 0,71% | 49 763 SH | 21 sierpnia 2026 | Dziennie |
| CGDG · Capital Group Dividend Growers ETF | 0,71% | 417 333 NS | 31 maja 2026 | N-PORT |